It was reported that low ip doses of STZ (40–50 mg/kg b.w.)result in the destruction of some of the population of β-cells in the pancreatic islets, and residual β-cells remain, which produce insufficient insulin, causing the T2DM model [20,21]. This evidence concerns the gene INS and type 2 diabetes mellitus.